Breaking News Instant updates and real-time market news.

09:25
01/08/20
01/08
09:25
01/08/20
09:25

UBS U.S. strategist to hold an analyst/industry conference call

U.S. Equity Strategist Trahan discusses the most important question every investor needs to answer: positioning for a recovery or a resumption of the slowdown trade? on an Analyst/Industry conference call to be held on January 8 at 10:30 am.

TODAY'S FREE FLY STORIES

Recommendations
bioMerieux price target raised to EUR 120 from EUR 118 at Berenberg » 12:37
09/23/20
09/23
12:37
09/23/20
12:37
BMXMF

bioMerieux

$0.00 /

+ (+0.00%)

Berenberg analyst Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BMXMF bioMerieux
$0.00 /

+ (+0.00%)

07/15/20 Kepler Cheuvreux
bioMerieux upgraded to Buy from Hold at Kepler Cheuvreux
07/13/20 Societe Generale
bioMerieux downgraded to Hold from Buy at Societe Generale
07/09/20 Oddo BHF
bioMerieux downgraded to Neutral from Buy at Oddo BHF
04/30/20 Berenberg
bioMerieux price target raised to EUR 118 from EUR 78 at Berenberg
Hot Stocks
Odonate jumps after Boxer Capital mention at Sohn Conference » 12:36
09/23/20
09/23
12:36
09/23/20
12:36
ODT

Odonate Therapeutics

$15.18 /

+0.67 (+4.62%)

Shares of Odonate…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ODT Odonate Therapeutics
$15.18 /

+0.67 (+4.62%)

ODT Odonate Therapeutics
$15.18 /

+0.67 (+4.62%)

08/24/20 Goldman Sachs
Odonate study met endpoint, but safety questions remain, says Goldman Sachs
12/06/19 Goldman Sachs
Odonate Therapeutics initiated with a Sell at Goldman Sachs
ODT Odonate Therapeutics
$15.18 /

+0.67 (+4.62%)

  • 28
    Aug
ODT Odonate Therapeutics
$15.18 /

+0.67 (+4.62%)

General news
FX Action: USD-JPY » 12:35
09/23/20
09/23
12:35
09/23/20
12:35

FX Action: USD-JPY…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Options
Foot Locker put volume heavy and directionally bearish » 12:35
09/23/20
09/23
12:35
09/23/20
12:35
FL

Foot Locker

$34.22 /

-0.35 (-1.01%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FL Foot Locker
$34.22 /

-0.35 (-1.01%)

FL Foot Locker
$34.22 /

-0.35 (-1.01%)

09/18/20
Fly Intel: Top five analyst upgrades
09/18/20 Argus
Foot Locker upgraded to Buy from Hold at Argus
09/08/20
Fly Intel: Top five analyst initiations
09/08/20 Goldman Sachs
Foot Locker initiated with a Buy at Goldman Sachs
FL Foot Locker
$34.22 /

-0.35 (-1.01%)

FL Foot Locker
$34.22 /

-0.35 (-1.01%)

FL Foot Locker
$34.22 /

-0.35 (-1.01%)

FL Foot Locker
$34.22 /

-0.35 (-1.01%)

Conference/Events
Jefferies video games analyst to hold an analyst/industry conference call » 12:28
09/23/20
09/23
12:28
09/23/20
12:28

Global Video Game…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Periodicals
EU, Novavax close to concluding preliminary talks on COVID vaccine, Reuters says » 12:28
09/23/20
09/23
12:28
09/23/20
12:28
NVAX

Novavax

$107.24 /

-4.4 (-3.94%)

Brussels is near to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVAX Novavax
$107.24 /

-4.4 (-3.94%)

NVAX Novavax
$107.24 /

-4.4 (-3.94%)

09/15/20 B. Riley FBR
Novavax deal with SIIPL doubles manufacturing capacity, says B. Riley FBR
09/09/20 B. Riley FBR
Astra trial hold opens window for other vaccine candidates, says B. Riley FBR
09/08/20 B. Riley FBR
Novavax selloff brings 'compelling' buying opportunity, says B. Riley FBR
09/03/20 Cantor Fitzgerald
Cantor says Novavax publication in NEJM gives 'validation' for vaccine candidate
NVAX Novavax
$107.24 /

-4.4 (-3.94%)

NVAX Novavax
$107.24 /

-4.4 (-3.94%)

NVAX Novavax
$107.24 /

-4.4 (-3.94%)

NVAX Novavax
$107.24 /

-4.4 (-3.94%)

Conference/Events
Enzo Biochem participates in a conference call hosted by JMP Securities » 12:27
09/23/20
09/23
12:27
09/23/20
12:27
ENZ

Enzo Biochem

$2.17 /

-0.11 (-4.82%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENZ Enzo Biochem
$2.17 /

-0.11 (-4.82%)

Conference/Events
Altimmune participates in a conference call hosted by JMP Securities » 12:26
09/23/20
09/23
12:26
09/23/20
12:26
ALT

Altimmune

$13.51 /

-0.835 (-5.82%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALT Altimmune
$13.51 /

-0.835 (-5.82%)

ALT Altimmune
$13.51 /

-0.835 (-5.82%)

09/22/20 Piper Sandler
Altimmune nearing two 'key stock-moving events,' says Piper Sandler
09/09/20 Piper Sandler
Piper sees 'no readthrough' to Altimmune from AstraZeneca COVID trial hold
08/25/20 Piper Sandler
Altimmune a 'stand out' from other COVID vaccine makers, says Piper Sandler
08/25/20 JMP Securities
Altimmune's AdCOVID to have 'unique advantages' over other vaccines, says JMP
ALT Altimmune
$13.51 /

-0.835 (-5.82%)

  • 14
    Jul
ALT Altimmune
$13.51 /

-0.835 (-5.82%)

ALT Altimmune
$13.51 /

-0.835 (-5.82%)

Conference/Events
Applied Genetic management to meet virtually with Roth Capital » 12:25
09/23/20
09/23
12:25
09/23/20
12:25
AGTC

Applied Genetic

$5.10 /

-0.06 (-1.16%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AGTC Applied Genetic
$5.10 /

-0.06 (-1.16%)

AGTC Applied Genetic
$5.10 /

-0.06 (-1.16%)

09/09/20 Roth Capital
Roth bumps up Applied Genetic price target to $26 after earnings, XLRP updates
09/03/20 Cantor Fitzgerald
Cantor sees positive risk/reward for Applied Genetic ahead of XLRP update
07/17/20 H.C. Wainwright
H.C. Wainwright says Applied Genetic still in 'pole position' in XLRP
07/01/20 Roth Capital
Applied Genetic may attract Sanofi takeover interest, says Roth Capital
AGTC Applied Genetic
$5.10 /

-0.06 (-1.16%)

  • 07
    Feb
Options
Under Armour call volume above normal and directionally bullish » 12:25
09/23/20
09/23
12:25
09/23/20
12:25
UA

Under Armour

$10.34 /

+0.8 (+8.39%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UA Under Armour
$10.34 /

+0.8 (+8.39%)

UA Under Armour
$10.34 /

+0.8 (+8.39%)

07/28/20 Jefferies
Under Armour 'inquiry matters, but it doesn't matter,' says Jefferies
07/23/20 Jefferies
Jefferies 'wouldn't chase' Nike shares near all-time highs
07/10/20 Morgan Stanley
Under Armour appears to be taking 'prudent look' at costs, says Morgan Stanley
05/12/20 Barclays
Under Armour price target lowered to $9 from $10 at Barclays
UA Under Armour
$10.34 /

+0.8 (+8.39%)

UA Under Armour
$10.34 /

+0.8 (+8.39%)

UA Under Armour
$10.34 /

+0.8 (+8.39%)

UA Under Armour
$10.34 /

+0.8 (+8.39%)

Syndicate
GoodRx opens at $46, IPO priced at $33 per share  12:23
09/23/20
09/23
12:23
09/23/20
12:23
GDRX

GoodRx

$0.00 /

+ (+0.00%)

 
ShowHide Related Items >><<
  • 23
    Sep
Conference/Events
Renewable Energy management to meet virtual with Truist » 12:21
09/23/20
09/23
12:21
09/23/20
12:21
REGI

Renewable Energy

$48.87 /

+1.38 (+2.91%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
REGI Renewable Energy
$48.87 /

+1.38 (+2.91%)

REGI Renewable Energy
$48.87 /

+1.38 (+2.91%)

09/02/20 Roth Capital
Renewable Energy price target raised to $50 from $33 at Roth Capital
09/01/20 Truist
Renewable Energy initiated with a Buy at Truist
09/01/20 Credit Suisse
Renewable Energy initiated with an Outperform at Credit Suisse
09/01/20 Truist
Renewable Energy initiated with a Buy at Truist
REGI Renewable Energy
$48.87 /

+1.38 (+2.91%)

REGI Renewable Energy
$48.87 /

+1.38 (+2.91%)

Conference/Events
Okta management to meet virtually with Truist » 12:19
09/23/20
09/23
12:19
09/23/20
12:19
OKTA

Okta

$210.89 /

-1.05 (-0.50%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OKTA Okta
$210.89 /

-1.05 (-0.50%)

OKTA Okta
$210.89 /

-1.05 (-0.50%)

08/28/20 DA Davidson
Okta price target raised to $250 from $210 at DA Davidson
08/28/20 BMO Capital
Okta price target raised to $228 from $205 at BMO Capital
08/28/20 JPMorgan
Okta price target raised to $250 from $192 at JPMorgan
08/28/20 Truist
Okta price target raised to $240 from $200 at Truist
OKTA Okta
$210.89 /

-1.05 (-0.50%)

OKTA Okta
$210.89 /

-1.05 (-0.50%)

OKTA Okta
$210.89 /

-1.05 (-0.50%)

OKTA Okta
$210.89 /

-1.05 (-0.50%)

Conference/Events
Nice management to meet virtually with Oppenheimer » 12:18
09/23/20
09/23
12:18
09/23/20
12:18
NICE

Nice

$221.15 /

-3.89 (-1.73%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NICE Nice
$221.15 /

-3.89 (-1.73%)

NICE Nice
$221.15 /

-3.89 (-1.73%)

09/16/20 Oppenheimer
Nice price target raised to $250 from $230 at Oppenheimer
09/16/20 Citi
Nice price target lowered to $254 from $262 at Citi
08/06/20 Jefferies
Nice price target raised to $265 from $195 at Jefferies
07/09/20 Citi
Nice upgraded to Buy on 'call center as a service' adoption at Citi
NICE Nice
$221.15 /

-3.89 (-1.73%)

Periodicals
EU, Novavax close to concluding preliminary talks on COVID vaccine, Reuters says  12:18
09/23/20
09/23
12:18
09/23/20
12:18
NVAX

Novavax

$106.78 /

-4.86 (-4.35%)

 
ShowHide Related Items >><<
NVAX Novavax
$106.78 /

-4.86 (-4.35%)

NVAX Novavax
$106.78 /

-4.86 (-4.35%)

09/15/20 B. Riley FBR
Novavax deal with SIIPL doubles manufacturing capacity, says B. Riley FBR
09/09/20 B. Riley FBR
Astra trial hold opens window for other vaccine candidates, says B. Riley FBR
09/08/20 B. Riley FBR
Novavax selloff brings 'compelling' buying opportunity, says B. Riley FBR
09/03/20 Cantor Fitzgerald
Cantor says Novavax publication in NEJM gives 'validation' for vaccine candidate
NVAX Novavax
$106.78 /

-4.86 (-4.35%)

NVAX Novavax
$106.78 /

-4.86 (-4.35%)

NVAX Novavax
$106.78 /

-4.86 (-4.35%)

NVAX Novavax
$106.78 /

-4.86 (-4.35%)

Conference/Events
Green Brick management to meet virtually with JMP Securities » 12:17
09/23/20
09/23
12:17
09/23/20
12:17
GRBK

Green Brick

$16.25 /

-0.71 (-4.19%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GRBK Green Brick
$16.25 /

-0.71 (-4.19%)

GRBK Green Brick
$16.25 /

-0.71 (-4.19%)

07/21/20 BTIG
Green Brick price target raised to $16 from $14 at BTIG
07/14/20 JMP Securities
Green Brick resumed with an Outperform at JMP Securities
06/23/20 BTIG
Green Brick price target raised to $14 from $11 at BTIG
06/11/20 JPMorgan
PulteGroup upgraded, KB downgraded as JPMorgan adjusts homebuilder ratings
GRBK Green Brick
$16.25 /

-0.71 (-4.19%)

GRBK Green Brick
$16.25 /

-0.71 (-4.19%)

Technical Analysis
NASDAQ market internals summary » 12:17
09/23/20
09/23
12:17
09/23/20
12:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Periodicals
Delta in talks to defer delivery of 40 Airbus jets past year end, Bloomberg says  12:16
09/23/20
09/23
12:16
09/23/20
12:16
EADSY

Airbus

$0.00 /

+ (+0.00%)

, DAL

Delta Air Lines

$30.29 /

+0.08 (+0.26%)

 
ShowHide Related Items >><<
EADSY Airbus
$0.00 /

+ (+0.00%)

DAL Delta Air Lines
$30.29 /

+0.08 (+0.26%)

EADSY Airbus
$0.00 /

+ (+0.00%)

09/17/20 Credit Suisse
Airbus price target raised to EUR 106 from EUR 78 at Credit Suisse
09/09/20
Fly Intel: Top five analyst downgrades
09/09/20 Morgan Stanley
Airbus downgraded to Equal Weight from Overweight at Morgan Stanley
08/10/20 JPMorgan
Airbus price target lowered to EUR 50 from EUR 54 at JPMorgan
DAL Delta Air Lines
$30.29 /

+0.08 (+0.26%)

09/18/20 Barclays
Delta Air Lines price target raised to $30 from $26 at Barclays
09/15/20 Seaport Global
Delta Air Lines initiated with a Buy at Seaport Global
09/08/20 Morgan Stanley
Delta Air Lines initiated with an Overweight at Morgan Stanley
09/02/20
Fly Intel: Top five analyst downgrades
EADSY Airbus
$0.00 /

+ (+0.00%)

DAL Delta Air Lines
$30.29 /

+0.08 (+0.26%)

EADSY Airbus
$0.00 /

+ (+0.00%)

DAL Delta Air Lines
$30.29 /

+0.08 (+0.26%)

EADSY Airbus
$0.00 /

+ (+0.00%)

DAL Delta Air Lines
$30.29 /

+0.08 (+0.26%)

DAL Delta Air Lines
$30.29 /

+0.08 (+0.26%)

Technical Analysis
NYSE market internals summary » 12:16
09/23/20
09/23
12:16
09/23/20
12:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is average for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

Conference/Events
Alkermes management to meet virtually with Mizuho » 12:15
09/23/20
09/23
12:15
09/23/20
12:15
ALKS

Alkermes

$17.19 /

+0.03 (+0.17%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALKS Alkermes
$17.19 /

+0.03 (+0.17%)

ALKS Alkermes
$17.19 /

+0.03 (+0.17%)

08/21/20 Mizuho
Alkermes comments on FDA panel may pressure shares, says Mizuho
07/30/20 Mizuho
Alkermes price target raised to $19 from $16 at Mizuho
07/30/20 Goldman Sachs
Alkermes downgraded to Sell from Neutral at Goldman Sachs
06/19/20 Piper Sandler
Biogen price target lowered to $260 from $307 at Piper Sandler
ALKS Alkermes
$17.19 /

+0.03 (+0.17%)

Recommendations
TUI AG price target lowered to 135 GBp at Citi » 12:15
09/23/20
09/23
12:15
09/23/20
12:15
TUIFY

TUI AG

$0.00 /

+ (+0.00%)

Citi analyst James Ainley…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TUIFY TUI AG
$0.00 /

+ (+0.00%)

11:50 Today Barclays
TUI AG price target lowered to 300 GBp from 400 GBp at Barclays
05/19/20 Commerzbank
TUI AG upgraded to Buy from Hold at Commerzbank
05/07/20 Morgan Stanley
TUI AG downgraded to Underweight from Equal Weight at Morgan Stanley
02/13/20 Commerzbank
TUI AG upgraded to Buy from Hold at Commerzbank
Conference/Events
BlackRock management to meet virtually with Jefferies » 12:14
09/23/20
09/23
12:14
09/23/20
12:14
BLK

BlackRock

$547.75 /

-2.97 (-0.54%)

Financial Analyst Fannon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BLK BlackRock
$547.75 /

-2.97 (-0.54%)

BLK BlackRock
$547.75 /

-2.97 (-0.54%)

07/20/20 Argus
BlackRock price target raised to $640 from $530 at Argus
07/20/20 BMO Capital
BlackRock price target raised to $620 from $560 at BMO Capital
07/20/20 Citi
BlackRock price target raised to $685 from $630 at Citi
07/13/20 Wells Fargo
BlackRock price target raised to $615 from $605 at Wells Fargo
BLK BlackRock
$547.75 /

-2.97 (-0.54%)

  • 13
    May
BLK BlackRock
$547.75 /

-2.97 (-0.54%)

BLK BlackRock
$547.75 /

-2.97 (-0.54%)

BLK BlackRock
$547.75 /

-2.97 (-0.54%)

Recommendations
Next plc price target raised to 6,550 GBp from 6,300 GBp at UBS » 12:12
09/23/20
09/23
12:12
09/23/20
12:12
NXGPY

Next plc

$0.00 /

+ (+0.00%)

UBS analyst Olivia…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NXGPY Next plc
$0.00 /

+ (+0.00%)

NXGPY Next plc
$0.00 /

+ (+0.00%)

09/18/20 JPMorgan
Next plc price target raised to 5,400 GBp from 4,900 GBp at JPMorgan
09/17/20 Liberum
Next plc downgraded to Hold from Buy at Liberum
09/04/20 Exane BNP Paribas
Next plc downgraded to Underperform from Neutral at Exane BNP Paribas
09/03/20 Morgan Stanley
Next plc downgraded to Underweight from Equal Weight at Morgan Stanley
On The Fly
Regenxbio slips as Novartis' Zolgensma expansion hits FDA roadblock » 12:10
09/23/20
09/23
12:10
09/23/20
12:10
NVS

Novartis

$88.10 /

-0.77 (-0.87%)

, RGNX

Regenxbio

$28.28 /

-0.59 (-2.04%)

, IONS

Ionis Pharmaceuticals

$50.11 /

-0.63 (-1.24%)

, BIIB

Biogen

$275.85 /

+3.07 (+1.13%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, PTCT

PTC Therapeutics

$46.18 /

+0.06 (+0.13%)

Shares of Regenxbio…

ShowHide Related Items >><<
NVS Novartis
$88.10 /

-0.77 (-0.87%)

RGNX Regenxbio
$28.28 /

-0.59 (-2.04%)

IONS Ionis Pharmaceuticals
$50.11 /

-0.63 (-1.24%)

BIIB Biogen
$275.85 /

+3.07 (+1.13%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PTCT PTC Therapeutics
$46.18 /

+0.06 (+0.13%)

NVS Novartis
$88.10 /

-0.77 (-0.87%)

09:34 Today BMO Capital
Ionis Pharmaceuticals' Spinraza benefits from Novartis' AVXS-101 delay, says BMO
09:13 Today SVB Leerink
Ionis should trade up, Regenxbio down after Novartis update, says SVB Leerink
05:22 Today Oddo BHF
Novartis downgraded to Neutral from Buy at Oddo BHF
09/10/20 UBS
Novartis upgraded to Buy from Neutral at UBS
RGNX Regenxbio
$28.28 /

-0.59 (-2.04%)

09:13 Today SVB Leerink
Ionis should trade up, Regenxbio down after Novartis update, says SVB Leerink
08/06/20 Roth Capital
Investors should buy 'highly undervalued' Clearside, says Roth Capital
06/25/20 BofA
Regenxbio reinstated with a Buy at BofA
05/12/20 RBC Capital
Regenxbio initiated with a Sector Perform at RBC Capital
IONS Ionis Pharmaceuticals
$50.11 /

-0.63 (-1.24%)

09:34 Today BMO Capital
Ionis Pharmaceuticals' Spinraza benefits from Novartis' AVXS-101 delay, says BMO
09:13 Today SVB Leerink
Ionis should trade up, Regenxbio down after Novartis update, says SVB Leerink
09/22/20 Cantor Fitzgerald
Ionis Pharmaceuticals price target raised to $59 from $56 at Cantor Fitzgerald
09/14/20 JPMorgan
Ionis Pharmaceuticals resumed with a Neutral at JPMorgan
BIIB Biogen
$275.85 /

+3.07 (+1.13%)

09:13 Today SVB Leerink
Ionis should trade up, Regenxbio down after Novartis update, says SVB Leerink
09/18/20 RBC Capital
Biogen price target lowered to $277 from $284 at RBC Capital
09/17/20 Morgan Stanley
Court ruling eliminates hurdle for Tecfidera generics, says Morgan Stanley
09/16/20 Raymond James
Mylan exclusivity on Tecfidera generic abruptly ending, says Raymond James
RHHBY Roche
$0.00 /

+ (+0.00%)

09:13 Today SVB Leerink
Ionis should trade up, Regenxbio down after Novartis update, says SVB Leerink
07:45 Today BMO Capital
Blueprint Medicines price target raised to $113 from $105 at BMO Capital
05:12 Today Oddo BHF
Roche downgraded to Reduce from Buy at Oddo BHF
09/21/20 H.C. Wainwright
Turning Point price target raised to $100 from $88 at H.C. Wainwright
PTCT PTC Therapeutics
$46.18 /

+0.06 (+0.13%)

09:13 Today SVB Leerink
Ionis should trade up, Regenxbio down after Novartis update, says SVB Leerink
08/24/20 Raymond James
PTC Therapeutics initiated with an Outperform at Raymond James
08/11/20 Cantor Fitzgerald
PTC Therapeutics price target lowered to $75 from $85 at Cantor Fitzgerald
07/20/20 Credit Suisse
Credit Suisse downgrades PTC Therapeutics after risdiplam royalty deal
NVS Novartis
$88.10 /

-0.77 (-0.87%)

RGNX Regenxbio
$28.28 /

-0.59 (-2.04%)

IONS Ionis Pharmaceuticals
$50.11 /

-0.63 (-1.24%)

BIIB Biogen
$275.85 /

+3.07 (+1.13%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PTCT PTC Therapeutics
$46.18 /

+0.06 (+0.13%)

NVS Novartis
$88.10 /

-0.77 (-0.87%)

BIIB Biogen
$275.85 /

+3.07 (+1.13%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PTCT PTC Therapeutics
$46.18 /

+0.06 (+0.13%)

NVS Novartis
$88.10 /

-0.77 (-0.87%)

IONS Ionis Pharmaceuticals
$50.11 /

-0.63 (-1.24%)

BIIB Biogen
$275.85 /

+3.07 (+1.13%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PTCT PTC Therapeutics
$46.18 /

+0.06 (+0.13%)

BIIB Biogen
$275.85 /

+3.07 (+1.13%)

BIIB Biogen
$275.85 /

+3.07 (+1.13%)

Hot Stocks
Spotify testing new Polls feature for podcasts » 12:09
09/23/20
09/23
12:09
09/23/20
12:09
SPOT

Spotify

$237.96 /

-3.54 (-1.47%)

Spotify said it is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPOT Spotify
$237.96 /

-3.54 (-1.47%)

SPOT Spotify
$237.96 /

-3.54 (-1.47%)

09/14/20 KeyBanc
Spotify initiated with a Sector Weight at KeyBanc
09/14/20 KeyBanc
Spotify initiated with a Sector Weight at KeyBanc
09/10/20
Fly Intel: Top five analyst upgrades
09/09/20 Credit Suisse
Credit Suisse raises Spotify subscriber estimates, upgrades to Outperform
SPOT Spotify
$237.96 /

-3.54 (-1.47%)

SPOT Spotify
$237.96 /

-3.54 (-1.47%)

SPOT Spotify
$237.96 /

-3.54 (-1.47%)

SPOT Spotify
$237.96 /

-3.54 (-1.47%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.